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Abstract
Background: It has been suggested that columnar cell lesions indicate an alteration of the human mammary
gland involved in the development of breast cancer. They have not previously been described in canine mammary
gland. The aim of this paper is describe the morphologic spectrum of columnar cell lesions in canine mammary
gland specimens and their association with other breast lesions.
Methods: A total of 126 lesions were subjected to a comprehensive morphological review based upon the human
breast classification system for columnar cell lesions. The presence of preinvasive (epithelial hyperplasia and in situ
carcinoma) and invasive lesions was determined and immunophenotypic analysis (estrogen receptor (ER),
progesterone receptor (PgR), high molecular weight cytokeratin (34bE-12), E-cadherin, Ki-67, HER-2 and P53) was
perfomed.
Results: Columnar cell lesions were identified in 67 (53.1%) of the 126 canine mammary glands with intraepithelial
alterations. They were observed in the terminal duct lobular units and characterized at dilated acini may be lined
by several layers of columnar epithelial cells with elongated nuclei. Of the columnar cell lesions identified, 41
(61.2%) were without and 26 (38.8%) with atypia. Association with ductal hyperplasia was observed in 45/67
(67.1%). Sixty (89.5%) of the columnar cell lesions coexisted with neoplastic lesions (20 in situ carcinomas, 19
invasive carcinomas and 21 benign tumors). The columnar cells were ER, PgR and E-cadherin positive but negative
for cytokeratin 34bE-12, HER-2 and P53. The proliferation rate as measured by Ki-67 appeared higher in the lesions
analyzed than in normal TDLUs.
Conclusions: Columnar cell lesions in canine mammary gland are pathologically and immunophenotypically
similar to those in human breast. This may suggest that dogs are a suitable model for the comparative study of
noninvasive breast lesions.
Background
The development of human breast cancer is believed to
be a complex multistep process originating in terminal
duct lobular units (TDLUs) and progressing towards
invasive cancer. Various precursor breast lesions have
been implicated in cancer development: atypical ductal
hyperplasia (ADH), atypical lobular hyperplasia (ALH),
lobular carcinoma in situ (LCIS), ductal carcinoma in
situ (DCIS) and more recently columnar cell lesions
(CCLs) [1,2].
Columnar cell lesions (CCL) of the human breast
comprise a group of conditions characterized by varying
degrees of acinar dilation in the TDLUs, lined by several
layers of columnar epithelial cells with uniform, ovoid
nuclei oriented perpendicular to the basement mem-
brane. The number of cellular layers enable CCLs to be
divided into two broad categories: columnar cell change
(CCC) [1-2 cell layers] or columnar cell hyperplasia
(CCH) [>2 cell layers]. CCC and CCH with cytological
atypia are further subclassified as flat epithelial atypia
(FEA) [3-5].
Recent observational studies and emerging genetic evi-
dence suggest that some CCLs, particularly those with
low-grade/monomorphic-type cytological atypia,
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any medium, provided the original work is properly cited.represent precursors to, or an early stage in the develop-
ment of, low-grade ductal carcinoma in situ (DCIS) and
invasive carcinoma [1,6].
The canine mammary gland bears significant patholo-
gical lesions similar to the human breast [7,8]. Breast
lesions in dogs show cellular changes involved in the
progression to invasive carcinoma. They are known as
atypical hyperplasia and carcinoma in situ [9-11]. These
descriptions may suggest that dogs are a promising
model animal for comparative oncology. Therefore, a
clearer account of the alterations in canine mammary
cancer will help to better understand the key steps in
the formation of human tumors.
In this paper we describe the presence of CCLs in
canine mammary gland specimens, their association
with other breast lesions and immunohistochemical
findings in a series of specimens.
Methods
Specimen selection
Specimens from one hundred and twenty-six consecutive
cases of canine mammary gland, with previous diagnosis
of epithelial lesions, were selected from the archives of
the Laboratory of Comparative Pathology of the Biologi-
cal Science Institute of the Federal University of Minas
Gerais. The mammary gland samples were obtained after
clinical diagnosis of mammary tumor and surgical
removal of the lesion. Hematoxylin and eosin-stained
sections were reviewed to search for columnar cell and
associated lesions. The ages of the animals at the time of
surgery ranged from 3 to 16 years (mean 9.8 years ± 2.2).
One human pathologist (HG) and two veterinary
pathologists (EF and GDC) individually reviewed and
classified the CCL in terms of the Schnitt and Vincent-
Salomon classification. Lesions were divided into two
categories according to their distinguishing morphologi-
cal features: columnar cell change (CCC) and columnar
cell hyperplasia (CCH), including subclassifications of
these according to the absence or presence of cytologi-
cal atypia (Table 1) [4,5]. A consensus classification was
achieved for each case by discussion and observation of
each individual lesion on a multihead microscope. The
canine mammary neoplasias and epithelial hyperplasias
were classified according to veterinary nomenclature
[12]. The association of CCL with malignant and benign
lesions was analyzed using Fisher’s exact test with signif-
icance at P < 0.05.
Immunohistochemistry
Considering the small size of the lesions, the immuno-
histochemical analysis were performed only on cases
with enough material. Paraffin blocks were selected
from six cases containg columnar cell lesions. Consecu-
tive 5 μm thick sections were obtained and mounted on
silanated slides for immunohistochemical study. Sections
were stained for rabbit polyclonal antibodies: HER-2
(c-erbB-2; Dako; dilution: 1:40), P53 (clone CM1; Cov-
ance; diluition: 1:80); and mouse monoclonal antibodies:
E-cadherin (clone 4A2C7; Zymed; dilution: 1:100),
ER-LH2 (clone CC4-5; Novocastra; dilution: 1:25), PgR
(clone hPRa2; Neomarkers; dilution: 1:20), Ki-67 (clone
Mib-1; Dako; dilution: 1:25), cytokeratins 1, 5, 10 and 14
(clone 34bE-12; Dako; dilution: 1:40). Heat-induced epi-
tope retrieval (20 min) usingD a k oa n t i g e nr e t r i e v a l
solution, pH 6.0 (Dako), was previously performed in a
water bath. The slides were then cooled to room tem-
perature for 20 min in the antigen retrieval buffer. The
sections were incubated at room temperature in 3%
(vol/vol) H2O2 for 15 min, in primary antibodies for 16
h, in reagent contained anti-mouse and anti-rabbit sec-
ondary antibodies (Biotinylated Goat Anti-polyvalent,
Laboratory Vision) for 15 min and streptavidin peroxi-
dase (UltraVision Large Volume Detection System, HRP,
Laboratory Vision) for 15 min. Between incubations, the
slides were washed for 2 × 5 min in phosphate-buffered
saline containing 1% (vol/vol) Tween 20. Immunoreac-
tivity was visualized by incubating the slides for 10 min
with diaminobenzidine (DAB Substrate System; Labora-
tory Vision). The slides were then counterstained with
Harris hematoxylin. Positive and negative control slides
Table 1 Histologic features of the different categories of columnar cell lesions in canine mammary gland.
Columnar Cell Change
without atypia
(CCC)
Columnar Cell Hyperplasia
(CCH)
Flat Epithelial Atypia (FEA) Flat Epithelial Atypia (FEA)
CCC with atypia CCH with atypia
One to two columnar cell
layers with uniform ovoid to
elongated nuclei; nucleoli
absent or inconspicuous.
Cellular stratification more than
two columnar cell layers with
uniform ovoid to elongated nuclei;
nucleoli absent or inconspicuous.
One to two columnar cell layers with
complex architectural patterns present;
Mild to moderate cytologic atypia
present (usually low-grade): round-to-
ovoid, mildly pleomorphic and
hyperchromatic nuclei, with
inconspicuous nucleoli.
Cellular stratification more than two
columnar cell layers with complex
architectural patterns present; Mild to
moderate cytologic atypia present
(usually low-grade): round-to- ovoid,
mildly pleomorphic and
hyperchromatic nuclei, with
inconspicuous nucleoli.
Classification categories are based on an expanded version of those describes by Schitt and Vincent- Salomon [5].
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used human breast cancer tissue known to express of
the antibodies. Negative controls were assessed using
normal serum (Ultra V Block, Laboratory Vision) as the
primary antibody.
Staining for ER, PgR, P53, CK34bE-12 and E-cadherin
was evaluated semi-quantitatively and scored into five
categories: negative (-), <5% of cells stained; positive (+),
5% to 25% of cells stained; positive (++), 25% to 50% of
cells stained; positive (+++), 50% to 75% of cells stained;
diffusely positive (++++), >75% of cells stained [13]. The
proliferative index was calculated by counting the posi-
tive nuclei for Ki-67 staining in a total of 500 columnar
cells from each lesion. HER-2 expression was defined as
epithelial cell membrane staining and scored according
to the American Society of Clinical Oncology, College
of American Pathologists [14].
All procedures were performed under the guidelines
and with the approval of the Ethics Committee in Animal
Experimentation (CETEA/UFMG), protocol 192/2006.
Results
CCLs were identified in 67 (53.1%) canine mammary
glands from the 126 specimens studied. CCL without
atypia were identified in 41/67 (61.1%) canine mammary
specimens. The CCC, 39 cases, were characterized by
dilated acini lined with a single layer of columnar
epithelial cells with elongated nuclei, a small amount of
cytoplasm and apical cytoplasm frequently containing
snouts and intraluminal secretions (Figure 1). Only two
specimens the columnar lesions showed more than two
cell layers and had prominent apical cytoplasmic snouts;
these were classified as columnar cell hyperplasia with-
out atypia (CCH) (Figure 2).
FEA was found in 26/67 (38.8%) (24 cases of CCCs
and 2 cases of CCHs) canine mammary lesions. In these
cases the alterations were characterized by the presence
of columnar epithelial cells with round to ovoid and/or
hyperchromatic nuclei that were not perpendicularly
oriented to the basement membrane, with a slight
increase in the nuclear/cytoplasmic ratio (Figure 3).
Focal micropapillae and tufting of cells were seen.
The intraluminal microcalcifications were detected in
columnar cell changes (6 cases without atypia and 6
cases with atypia) and in columnar cell hyperplasia (only
1 case without atypia).
Associated lesions were represented only by ductal
and lobular hyperplasias and epithelial neoplastic
lesions. Sixty cases of the CCLs (89.5%) showed coexist-
ing neoplastic lesions (20 ductal carcinomas in situ,1 9
invasive carcinomas and 21 benign tumors). We found a
higher prevalence of FEA with ductal carcinomas in situ
(13 cases; 50%) than invasive carcinomas (5 cases; 19%)
and benign tumors (3 cases; 11.5%). CCCs were detected
in association with 18 benign tumors (46.1%), 7 ductal
carcinomas in situ (17.9%) and 12 invasive carcinomas
(30.7%) (P < 0.05). Two cases of CCH proved to be
associated with invasive carcinoma (Table 2).
Ductal hyperplasia was associated with CCLs in 45/67
(67.1%) cases (23 without atypia and 22 with atypia)
(Figure 1D). Two cases of CCHs was associated with
ductal hyperplasia. Only one atypical lobular hyperplasia
was detected. This lesion was associated with columnar
cell hyperplasia without atypia and in situ carcinoma.
FEA was associated with ductal hyperplasias with atypia
in 12 out 17 cases and CCC was more frequently asso-
ciated with hyperplasias without atypia: 17 out 26 cases
(P < 0.05) (Table 3).
The luminal epithelial cells with columnar change
(five CCC and one CCH) showed a strong uniform
nuclear immunopositivity for ER and PR antibodies in
50% and around 100% of cells respectively in all six
cases studied (Figure 4A and 4B). Strong E-cadherin
expression was detected in 5 out of 6 CCLs analyzed
with a staining pattern similar to the adjacent normal
TDLU. Within these specimens, three cases exhibited
strong E-cadherin immunoreactivity in all cells and two
exhibited strong immunoreactivity but with focal areas
of reduced or absent immunostaining, typically affecting
small isolated tufts of cells (Figure 4C).
Figure 1 Canine mammary biopsies with columnar cell change
without atypia (CCC) H&E stain. 1A Low-power view, showing
dilated mammary acini in a TDLU lined with a single layer of
epithelial columnar cells with underlying myoepithelial cells, many
of which contain intraluminal secretions and many hyperplastic foci,
200×; 1B, 1C e 1D At higher magnification, the lining columnar
cells with uniform ovoid to elongated nuclei and nucleoli absent.
Many contain intraluminal secretions (1B) and show a small apical
snout (1C) and intraluminal calcifications (1D), 600×.
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higher in CCLs (mean 4.7%) than normal TDLU. Ki-67-
positive cells were generally present but in low numbers
in normal internal control tissue epithelium (<1% posi-
tive cells) (Figure 4D).
The CCLs were negative for cytokeratin 34bE-12, P53
and HER-2 in all six cases studied. Interestingly, P53
and HER-2 negative results were similar to those
obtained with the associated benign and malignant
tumors (two benign mixed tumors, one duct papilloma,
one solid carcinoma and two ductal in situ carcinoma).
Discussion
Columnar cell alterations of the canine mammary gland
have been documented during microscopic analysis of
breast tissues. A common component of most hyper-
plastic ductal lesions was columnar alteration (also
referred to as columnar cell metaplasia) [12]. However,
histopathological criteria that characterize columnar
Figure 2 Canine mammary biopsies with columnar cell
hyperplasia without atypia (CCH) H&E stain. 2A Low-power
view, terminal duct lobular unit with cellular stratification, more than
two cell layers, 100×. 2B Higher power view; columnar cells with
uniform ovoid to elongated nuclei, observed hobnail cells with
nucleoli absent or inconspicuous, 600×.
Figure 3 Canine mammary biopsies with flat epithelial atypia
(FEA) H&E stain. 3A Low-power view; terminal duct lobular unit
shows larger acini with cellular atypia, prominent apical cytoplasmic
snouts, to be lined by >2 cell layers. 200×; 3B Higher power view;
the columnar epithelial cells (> 2 layers) lining the acini with
intraluminal secretions show cytological atypia, characterized by
apical cytoplasmic snouts and enlarged, uniform nuclei; the nuclear/
cytoplasmic ratio is increased. Nucleoli are evident in some of the
nuclei, 600×.
Table 2 Types of canine mammary columnar cell lesions
and associated neoplastic alterations.
Tumor types
(**) CCC(%) CCH
(%)
FEA(%) Total(%)
invasive carcinomas 12 (30.7) - 5 (19.2) 19 (28.4)
carcinoma in benign
tumor
6 (15.3) 2
(100)
3 (11.5)
solid carcinoma 2 (5.1) - 2 (7.2)
tubulopapillary
carcinoma
4 (10.3) --
ductal carcinoma in situ 7 (17.9) - 13 (50.0)
(*) 20 (29.8)
benign tumors 18 (46.1)
(*) 3 (11.5) 21 (31.4)
simple adenoma 3 (7.6) - -
duct papilloma 7 (17.9) - 1 (3.8)
benign mixed tumor 8 (20.6) - 2 (7.7)
without tumor 2 (5.1) - 5 (19.2) 7 (10.4)
Total 39 (100) 2
(100)
26 (100) 67 (100)
(*)Flat epithelial atypia presence is often associated with in situ carcinomas
and columnar cell lesion without atypia are more frequent in benign tumors
(P < 0,05).
(**)Misdorp,1999. International Histological Classification of Tumors of Domestic
Animals.
CCC: columnar cell change without atypia; CCH: columnar cell hyperplasia
without atypia; FEA: flat epithelial atypia
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detected as the sole histopathological abnormality fol-
lowing breast biopsy are undocumented.
The morphological appearance of the canine CCLs
was very similar to the human breast. Hyperplastic
breast lesions, such as ductal hyperplasias without and
with atypia, have previously been described in the
canine mammary gland [12]. To our knowledge, our
study is the first to describe CCLs in the mammary
glands of female dogs. In the present study we found
CCLs in 53.1% of consecutive canine breast specimens.
Lesions ranged from CCCs without atypia (61.1%) to
FEA (38.8%).
Observational studies have revealed a relationship
between CCLs and tubular carcinoma [15,16]. Columnar
cell lesions, in particular those with nuclear atypia, may
also co-exist with lobular in situ neoplasia. Flat epithelial
atypia is associated with established DCIS more fre-
quently than by chance [17,18].
Microcalcifications were also frequently found in asso-
ciation with canine CCLs, similar to human lesions.
Although CCLs have long been recognized in the
human breast under different names, their importance
increased after more were diagnosed in mammographi-
cally detected lesions owing to microcalcifications
[16,18]. Although mammography is not routinely used
in canine species we supposed that such microcalcifica-
tions would have a radiological appearance similar to
that in the human breast.
Myoepithelial/basal and some epithelial cells in human
CCLs are positive for CK5/6 [19]. Though columnar cell
lesions in human breast are usually negative for HER-2/
neu, p53 and basal CK5/6 and CK14. Similar expression
was found in all six cases studied, supporting the use of
breast tumor biomarkers in this model. The immunohis-
tochemical similarities between human and dog colum-
nar cells also included, increased epithelial expression of
the proliferation marker Ki-67/MIB1 and strong expres-
sion of hormonal receptors (ER and PR) and E-cadherin
[13,20,21].
The canine species could be the most adequate model
for new studies for cancer, due to the morphological
and genotypic similarities of human lesions [20,22,23].
Spontaneous epithelial mammary lesions are common in
dogs well before the age of onset of palpable mammary
tumors [9,7]. Thus, spontaneous tumours of canine
mammary glands have been proposed as comparative
models for the study of human breast cancer, since
these lesions share epidemiological, clinical, behavioural
and antigenic features [23-25].
Conclusions
Columnar cell lesions in canine mammary gland are
pathologically and immunophenotypically similar to those
in human breast. This may suggest that dogs are a suitable
model for the comparative study of noninvasive breast
Table 3 Types of canine mammary columnar cell lesions and associated ductal hyperplasia in presence of different
tumors types.
Tumor types
(**) CCC(%) CCH(%) FEA(%) Total(%)
DH ADH DH ADH DH ADH
invasive carcinomas 3 (11.5) 3 (11.5) 1 (50.0) 1 (50.0) - 3 (17.6) 11 (24.4)
ductal carcinoma in situ 2 (7.7) 2 (7.7) - - 3 (17.6) 4 (23.5) 11 (24.4)
benign tumors 10 (38.5) 4 (15.4) - - 1 (5.9) 1 (5.9) 16 (35.6)
without tumor 2 (7.7) - - - 1 (5.9) 4 (23.5) 7 (15.6)
Total 17 (65.4)
(*) 9 (34.6) 1 (50.0) 1 (50.0) 5 (29.4) 12 (70.6)
(*) 45 (100)
(*)Flat epithelial atypia is often associated with ductal hyperplasias with atypia (ADH) and columnar cell changes witout atypia are more frequent in hyperplasias
without atypia (UDH) (19/30) (P < 0.05).
(**)Misdorp,1999. International Histological Classification of Tumors of Domestic Animals.
CCC: columnar cell change; CCH: columnar cell hyperplasia without atypia; FEA: flat epithelial atypia; DH: ductal hyperplasia without atypia; ADH: atypical ductal
hyperplasia;
Figure 4 Canine mammary biopsies with immunohistochemical
staining of columnar cell lesion (CCL). Columnar cell change
without atypia showing intense immunostaining for estrogen
receptor (4A) and progesterone receptor (4B). Flat epithelial atypia
with moderate membrane E-cadherin reactivity (4C) and nuclear
expression for Ki-67 (4D), 600×.
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quency of columnar cells lesions and their relationship to
in situ carcinomas in canine mammary glands to provide a
model for testing treatment modalities for mammary
lesions and ultimately for clarifying patient management.
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